Terms: = Liver cancer AND SH3GL1, Q99961, 6455, ENSG00000141985, SH3D2B, EEN, CNSA1, SH3P8 AND Treatment
1 results:
1. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting sh3gl1 and negatively regulating EGFR/ERK/NF-κB signaling.
Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y
Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155
[TBL] [Abstract] [Full Text] [Related]
